Fingerprint
Dive into the research topics of 'Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
EXPAND Clinical Investigators
Research output: Contribution to journal › Article › peer-review
644
Scopus
citations